Market Research

Cancer Profiling Market (Product: Instruments and Consumables; and Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, and Others - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 195 Pages Transparency Market Research Pvt. Ltd. June, 2023 TNPR18094198
Best Price Guarantee
Price from $5,795
Length 195 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date June, 2023
SKU TNPR18094198

Cancer Profiling Market (Product: Instruments and Consumables; and Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, and Others - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Cancer Profiling Market – Scope of Report


TMR’s report on the global Cancer Profiling Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Cancer Profiling Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Cancer Profiling Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Cancer Profiling Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Cancer Profiling Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Cancer Profiling Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Cancer Profiling Market.

The report delves into the competitive landscape of the global Cancer Profiling Market. Key players operating in the global Cancer Profiling Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Cancer Profiling Market profiled in this report.

Key Questions Answered in Global Cancer Profiling Market Report
  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Cancer Profiling Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Cancer Profiling Market – Research Objectives and Research Approach

The comprehensive report on the global Cancer Profiling Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Cancer Profiling Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Cancer Profiling.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cancer Profiling Market
4. Market Overview
  4.1. Introduction
4.1.1. Segment Definition
  4.2. Overview
  4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
  4.4. Global Cancer Profiling Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
  5.1. Regulatory Scenario for Cancer Profiling
  5.2. Cancer Epidemiology, by Region
  5.3. Technological Advancements in Cancer Profiling Technology
  5.4. COVID-19 Impact on the Industry
6. Global Cancer Profiling Market Analysis and Forecast, by Product
  6.1. Introduction & Definition
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Instruments
6.3.1.1. Immunohistochemistry Analyzers
6.3.1.2. In Situ Hybridization Instruments
6.3.1.3. Polymerase Chain Reaction Instruments
6.3.1.4. DNA Sequencers
6.3.1.5. Fragment Analyzers
6.3.2. Consumables
6.3.2.1. Reagents & Kits
6.3.2.2. Others
  6.4. Market Attractiveness Analysis, by Product
7. Global Cancer Profiling Market Analysis and Forecast, by Technology
  7.1. Introduction & Definition
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Technology, 2017-2031
7.3.1. Immunohistochemistry
7.3.2. Next Generation Sequencing
7.3.3. Polymerase Chain Reaction
7.3.4. In Situ Hybridization
7.3.5. Microarrays
7.3.6. Fragment Analysis
7.3.7. Others
  7.4. Market Attractiveness Analysis, by Technology
8. Global Cancer Profiling Market Analysis and Forecast, by Cancer Type
  8.1. Introduction & Definition
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by Cancer Type, 2017-2031
8.3.1. Breast Cancer
8.3.2. Lung Cancer
8.3.3. Colorectal Cancer
8.3.4. Prostate Cancer
8.3.5. Prostate Cancer
8.3.6. Melanoma
8.3.7. Others
  8.4. Market Attractiveness Analysis, by Cancer Type
9. Global Cancer Profiling Market Analysis and Forecast, by End-user
  9.1. Introduction & Definition
  9.2. Key Findings/Developments
  9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Cancer Research Institutes
9.3.4. Others
  9.4. Market Attractiveness Analysis, by End-user
10. Global Cancer Profiling Market Analysis and Forecast, by Region
  10.1. Key Findings
  10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
  10.3. Market Attractiveness By Country/Region
11. North America Cancer Profiling Market Analysis and Forecast
  11.1. Introduction
11.1.1. Key Findings
  11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. Instruments
11.2.1.1. Immunohistochemistry Analyzers
11.2.1.2. In Situ Hybridization Instruments
11.2.1.3. Polymerase Chain Reaction Instruments
11.2.1.4. DNA Sequencers
11.2.1.5. Fragment Analyzers
11.2.2. Consumables
11.2.2.1. Reagents & Kits
11.2.2.2. Others
  11.3. Market Value Forecast, by Technology, 2017-2031
11.3.1. Immunohistochemistry
11.3.2. Next Generation Sequencing
11.3.3. Polymerase Chain Reaction
11.3.4. In Situ Hybridization
11.3.5. Microarrays
11.3.6. Fragment Analysis
11.3.7. Others
  11.4. Market Value Forecast, by Cancer Type, 2017-2031
11.4.1. Breast Cancer
11.4.2. Lung Cancer
11.4.3. Colorectal Cancer
11.4.4. Prostate Cancer
11.4.5. Prostate Cancer
11.4.6. Melanoma
11.4.7. Others
  11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Hospitals
11.5.2. Diagnostic Centers
11.5.3. Cancer Research Institutes
11.5.4. Others
  11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
11.6.1. U.S.
11.6.2. Canada
  11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Technology
11.7.3. By Cancer Type
11.7.4. By End-user
11.7.5. By Country
12. Europe Cancer Profiling Market Analysis and Forecast
  12.1. Introduction
12.1.1. Key Findings
  12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. Instruments
12.2.1.1. Immunohistochemistry Analyzers
12.2.1.2. In Situ Hybridization Instruments
12.2.1.3. Polymerase Chain Reaction Instruments
12.2.1.4. DNA Sequencers
12.2.1.5. Fragment Analyzers
12.2.2. Consumables
12.2.2.1. Reagents & Kits
12.2.2.2. Others
  12.3. Market Value Forecast, by Technology, 2017-2031
12.3.1. Immunohistochemistry
12.3.2. Next Generation Sequencing
12.3.3. Polymerase Chain Reaction
12.3.4. In Situ Hybridization
12.3.5. Microarrays
12.3.6. Fragment Analysis
12.3.7. Others
  12.4. Market Value Forecast, by Cancer Type, 2017-2031
12.4.1. Breast Cancer
12.4.2. Lung Cancer
12.4.3. Colorectal Cancer
12.4.4. Prostate Cancer
12.4.5. Prostate Cancer
12.4.6. Melanoma
12.4.7. Others
  12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Hospitals
12.5.2. Diagnostic Centers
12.5.3. Cancer Research Institutes
12.5.4. Others
  12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
  12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Technology
12.7.3. By Cancer Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Cancer Profiling Market Analysis and Forecast
  13.1. Introduction
13.1.1. Key Findings
  13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. Instruments
13.2.1.1. Immunohistochemistry Analyzers
13.2.1.2. In Situ Hybridization Instruments
13.2.1.3. Polymerase Chain Reaction Instruments
13.2.1.4. DNA Sequencers
13.2.1.5. Fragment Analyzers
13.2.2. Consumables
13.2.2.1. Reagents & Kits
13.2.2.2. Others
  13.3. Market Value Forecast, by Technology, 2017-2031
13.3.1. Immunohistochemistry
13.3.2. Next Generation Sequencing
13.3.3. Polymerase Chain Reaction
13.3.4. In Situ Hybridization
13.3.5. Microarrays
13.3.6. Fragment Analysis
13.3.7. Others
  13.4. Market Value Forecast, by Cancer Type, 2017-2031
13.4.1. Breast Cancer
13.4.2. Lung Cancer
13.4.3. Colorectal Cancer
13.4.4. Prostate Cancer
13.4.5. Prostate Cancer
13.4.6. Melanoma
13.4.7. Others
  13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Hospitals
13.5.2. Diagnostic Centers
13.5.3. Cancer Research Institutes
13.5.4. Others
  13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
  13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Technology
13.7.3. By Cancer Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Cancer Profiling Market Analysis and Forecast
  14.1. Introduction
14.1.1. Key Findings
  14.2. Market Value Forecast, by Product, 2017-2031
14.2.1. Instruments
14.2.1.1. Immunohistochemistry Analyzers
14.2.1.2. In Situ Hybridization Instruments
14.2.1.3. Polymerase Chain Reaction Instruments
14.2.1.4. DNA Sequencers
14.2.1.5. Fragment Analyzers
14.2.2. Consumables
14.2.2.1. Reagents & Kits
14.2.2.2. Others
  14.3. Market Value Forecast, by Technology, 2017-2031
14.3.1. Immunohistochemistry
14.3.2. Next Generation Sequencing
14.3.3. Polymerase Chain Reaction
14.3.4. In Situ Hybridization
14.3.5. Microarrays
14.3.6. Fragment Analysis
14.3.7. Others
  14.4. Market Value Forecast, by Cancer Type, 2017-2031
14.4.1. Breast Cancer
14.4.2. Lung Cancer
14.4.3. Colorectal Cancer
14.4.4. Prostate Cancer
14.4.5. Prostate Cancer
14.4.6. Melanoma
14.4.7. Others
  14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Hospitals
14.5.2. Diagnostic Centers
14.5.3. Cancer Research Institutes
14.5.4. Others
  14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
  14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Technology
14.7.3. By Cancer Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Cancer Profiling Market Analysis and Forecast
  15.1. Introduction
15.1.1. Key Findings
  15.2. Market Value Forecast, by Product, 2017-2031
15.2.1. Instruments
15.2.1.1. Immunohistochemistry Analyzers
15.2.1.2. In Situ Hybridization Instruments
15.2.1.3. Polymerase Chain Reaction Instruments
15.2.1.4. DNA Sequencers
15.2.1.5. Fragment Analyzers
15.2.2. Consumables
15.2.2.1. Reagents & Kits
15.2.2.2. Others
  15.3. Market Value Forecast, by Technology, 2017-2031
15.3.1. Immunohistochemistry
15.3.2. Next Generation Sequencing
15.3.3. Polymerase Chain Reaction
15.3.4. In Situ Hybridization
15.3.5. Microarrays
15.3.6. Fragment Analysis
15.3.7. Others
  15.4. Market Value Forecast, by Cancer Type, 2017-2031
15.4.1. Breast Cancer
15.4.2. Lung Cancer
15.4.3. Colorectal Cancer
15.4.4. Prostate Cancer
15.4.5. Prostate Cancer
15.4.6. Melanoma
15.4.7. Others
  15.5. Market Value Forecast, by End-user, 2017-2031
15.5.1. Hospitals
15.5.2. Diagnostic Centers
15.5.3. Cancer Research Institutes
15.5.4. Others
  15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
  15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Technology
15.7.3. By Cancer Type
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
  16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  16.2. Market Share Analysis, by Company (2022)
  16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Agilent Technologies Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. F. Hoffmann-La Roche Ltd
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. HTG Molecular Diagnostics, Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Illumina, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. PerkinElmer Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. QIAGEN N.V.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Siemens Healthineers
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Sysmex Corporation
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Thermo Fisher Scientific Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Hologic, Inc.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Guardant Health
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings